Mitsui Fudosan is set to exit the AIOps software developer, which has agreed to an acquisition by ServiceNow two months after its series B round.

The networking technology developer, which had raised $27m from investors including Intel Capital, is set to be acquired by VMWare.

Axa is set to exit residential engagement app developer Modern Message, which has agreed to be bought by RealPage.

Revolution Medicines, based on research from University of Illinois at Urbana-Champaign, Stanford University and UC Berkeley, has filed for a $100m initial public offering.

Sanofi is in line for an exit as Revolution Medicines files for a $100m initial public offering on the Nasdaq Global Market.

Zomato is acquiring Uber's local Uber Eats business in a transaction that involves it giving a sizeable equity stake to the ride hailing platform.

Bertelsmann achieved an exit as the cloud services provider raised $284m in an initial public offering that reportedly valued it at about $2bn.

The Bertelsmann, UCommune and Ant Financial-backed property manager raised nearly $130m depite downsizing its initial public offering.

The Tasly and Genexine-backed drug developer floated above the mid-point of its range, in an initial public offering that could end up topping $119m.

The Xiaomi-backed, China-headquartered podcast app developer priced its shares at the bottom of their range to raise $45.1m in a US offering.